155 related articles for article (PubMed ID: 25544963)
1. Correlations of ezrin expression with pathological characteristics and prognosis of osteosarcoma: a meta-analysis.
Zhao DH; Zhu J; Wang WB; Dong F; Zhang Q; Fan HW; Zhang JZ; Wang YM
ScientificWorldJournal; 2014; 2014():837543. PubMed ID: 25544963
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of elevated ezrin in patients with osteosarcoma.
Lun DX; Hu YC; Xu ZW; Xu LN; Wang BW
Tumour Biol; 2014 Feb; 35(2):1263-6. PubMed ID: 24014052
[TBL] [Abstract][Full Text] [Related]
3. The Prognostic Role of Ezrin Immunoexpression in Osteosarcoma: A Meta-Analysis of Published Data.
Li H; Min D; Zhao H; Wang Z; Qi W; Zheng S; Tang L; He A; Sun Y; Yao Y; Shen Z
PLoS One; 2013; 8(6):e64513. PubMed ID: 23805177
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of microRNA-183/Ezrin axis in judging the prognosis of patients with osteosarcoma.
Mu Y; Zhang H; Che L; Li K
Med Oncol; 2014 Feb; 31(2):821. PubMed ID: 24352761
[TBL] [Abstract][Full Text] [Related]
5. Ezrin expression predicts survival in stage IIB osteosarcomas.
Kim MS; Song WS; Cho WH; Lee SY; Jeon DG
Clin Orthop Relat Res; 2007 Jun; 459():229-36. PubMed ID: 17353802
[TBL] [Abstract][Full Text] [Related]
6. Expression change of ezrin as a prognostic factor in primary osteosarcoma.
Wang YF; Shen JN; Xie XB; Wang J; Huang G
Med Oncol; 2011 Dec; 28 Suppl 1():S636-43. PubMed ID: 20859706
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of associations of the ezrin gene with human osteosarcoma response to chemotherapy and prognosis.
Wang Z; He ML; Zhao JM; Qing HH; Wu Y
Asian Pac J Cancer Prev; 2013; 14(5):2753-8. PubMed ID: 23803027
[TBL] [Abstract][Full Text] [Related]
8. Ezrin and alpha-smooth muscle actin are immunohistochemical prognostic markers in conventional osteosarcomas.
Salas S; Bartoli C; Deville JL; Gaudart J; Fina F; Calisti A; Bollini G; Curvale G; Gentet JC; Duffaud F; Figarella-Branger D; Bouvier C
Virchows Arch; 2007 Dec; 451(6):999-1007. PubMed ID: 17786474
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of immunohistochemical expression of ezrin in non-metastatic high-grade osteosarcoma.
Ferrari S; Zanella L; Alberghini M; Palmerini E; Staals E; Bacchini P
Pediatr Blood Cancer; 2008 Apr; 50(4):752-6. PubMed ID: 17886294
[TBL] [Abstract][Full Text] [Related]
10. Immunoexpression of Ezrin and CD44 in patients with osteosarcoma.
Boldrini E; Peres SV; Morini S; de Camargo B
J Pediatr Hematol Oncol; 2010 Aug; 32(6):e213-7. PubMed ID: 20562647
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of miR-183 promotes migration and invasion of osteosarcoma by targeting Ezrin.
Zhu J; Feng Y; Ke Z; Yang Z; Zhou J; Huang X; Wang L
Am J Pathol; 2012 Jun; 180(6):2440-51. PubMed ID: 22525461
[TBL] [Abstract][Full Text] [Related]
12. Ezrin in osteosarcoma: comparison between conventional high-grade and central low-grade osteosarcoma.
Park HR; Jung WW; Bacchini P; Bertoni F; Kim YW; Park YK
Pathol Res Pract; 2006; 202(7):509-15. PubMed ID: 16677779
[TBL] [Abstract][Full Text] [Related]
13. The Prognostic Role of Ezrin and HER2/neu Expression in Osteosarcoma.
Abdou AG; Kandil M; Asaad NY; Dawoud MM; Shahin AA; Abd Eldayem AF
Appl Immunohistochem Mol Morphol; 2016; 24(5):355-63. PubMed ID: 26067138
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylated ezrin is located in the nucleus of the osteosarcoma cell.
Di Cristofano C; Leopizzi M; Miraglia A; Sardella B; Moretti V; Ferrara A; Petrozza V; Della Rocca C
Mod Pathol; 2010 Jul; 23(7):1012-20. PubMed ID: 20348881
[TBL] [Abstract][Full Text] [Related]
15. Effects of vascular endothelial growth factor expression on pathological characteristics and prognosis of osteosarcoma.
Han G; Wang Y; Bi W; Jia J; Wang W; Xu M
Clin Exp Med; 2016 Nov; 16(4):577-584. PubMed ID: 26319790
[TBL] [Abstract][Full Text] [Related]
16. The actin-cytoskeleton linker protein ezrin is regulated during osteosarcoma metastasis by PKC.
Ren L; Hong SH; Cassavaugh J; Osborne T; Chou AJ; Kim SY; Gorlick R; Hewitt SM; Khanna C
Oncogene; 2009 Feb; 28(6):792-802. PubMed ID: 19060919
[TBL] [Abstract][Full Text] [Related]
17. Expression of Ezrin correlates with lung metastasis in Chinese patients with osteosarcoma.
Xu-Dong S; Zan S; Shui-er Z; Li-na T; Wen-xi Y; Feng L; Yang Y
Clin Invest Med; 2009 Apr; 32(2):E180-8. PubMed ID: 19331807
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-144 inhibits the proliferation, apoptosis, invasion, and migration of osteosarcoma cell line F5M2.
Cui SQ; Wang H
Tumour Biol; 2015 Sep; 36(9):6949-58. PubMed ID: 25854173
[TBL] [Abstract][Full Text] [Related]
19. The relationship between the expression of Ki-67 and the prognosis of osteosarcoma.
Zeng M; Zhou J; Wen L; Zhu Y; Luo Y; Wang W
BMC Cancer; 2021 Mar; 21(1):210. PubMed ID: 33648449
[TBL] [Abstract][Full Text] [Related]
20. microRNA-96 acts as a tumor suppressor gene in human osteosarcoma via target regulation of EZRIN.
Yao Q; Pei Y; Zhang X; Xie B
Life Sci; 2018 Jun; 203():1-11. PubMed ID: 29656060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
